Description
You did not choose your diagnosis, but you can choose to do something about it. For your journey ahead, there's OFEV® capsules. OFEV was first approved in 2014 to treat adults with IPF, one of the most common ILDs. In 2019, it became the first FDA-approved therapy to slow the rate of decline in lung function in adults with SSc-ILD. Today, OFEV is also approved to treat adults with a long lasting (chronic) ILD in which lung fibrosis continues to worsen (progress).
This professional campaign titled 'Because Every Moment Counts' was published in United Arab Emirates in September, 2024. It was created for the brands: Boehringer Ingelheim and Ofev, by ad agency: Mojo creative studio. This Design, Digital, and Print media campaign is related to the Health and Pharmaceutical industries and contains 1 media asset. It was submitted about 1 year ago by Creative /Art Director: Ramy Mohamed of Mojo Creative Studio.
Credits
Client: Boehringer Ingelheim
Slogan: Because Every Moment Counts
Advertising Agency: Mojo creative Studio, Cairo, Egypt
Creative Director: Ramy Mohamed
Art Director: Ramy Mohamed
Copy Writer: Cerine Chalfoun - Amel Eid
